Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Vergote, Ignace;Van Nieuwenhuysen, Els;O'Cearbhaill, Roisin E.;Westermann, Anneke;Lorusso, Domenica;Ghamande, Sharad;Collins, Dearbhaile C.;Banerjee, Susana;Mathews, Cara A.;Gennigens, Christine;Cibula, David;Tewari, Krishnansu S.;Madsen, Kristine;Köse, Fatih;Jackson, Amanda L.;Boere, Ingrid A.;Scambia, Giovanni;Randall, Leslie M.;Sadozye, Azmat;Baurain, Jean-François;Gort, Eelke;Zikán, Michal;Denys, Hannelore G.;Ottevanger, Nelleke;Forget, Frédéric;Mondrup Andreassen, Camilla;Eaton, Lamar;Chisamore, Michael J.;Viana Nicacio, Leonardo;Soumaoro, Ibrahima;Monk, Bradley J.

2024-01-01